Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$174.81 - $241.14 $56,813 - $78,370
-325 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$166.16 - $213.96 $54,002 - $69,537
325 New
325 $58,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Sandy Cove Advisors, LLC Portfolio

Follow Sandy Cove Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Cove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Cove Advisors, LLC with notifications on news.